Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis.
Overview
- Department of Pediatric Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Department of Neurosurgery, Beijing Neurosurgical Institute, Beijing, China
- Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei City, Anhui Province, China
Abstract
Objective: Medulloblastoma (MB) is one of the most prevalent solid brain tumors in the pediatric population. Although hundreds of Differentially Expressed Genes (DEGs) have been identified as diagnostic molecules and therapeutic targets for Medulloblastoma (MB), the function of metabolism-associated genes in the pathophysiological mechanisms of MB remains unclear.
Methods: The Gene Expression Omnibus (GEO) provided five datasets that contain mRNA expression profiles and clinical information. In detail, 599 MB samples extracted from GSE85217 were set as the training set (n = 400) and test set (n = 199). For validation, 74 samples from GSE37418, 8 scRNA-seq samples, and 37 RNA-seq samples were used. Nonnegative matrix factorization clustering was conducted, leading to the identification of four MB subclasses (C1, C2, C3, and C4) in both the training and test sets.
Results: C1 and C3 are metabolically active, and C2 involves metabolic hypoactivity; C4 did not exhibit obvious metabolic characteristics. Next, GSE50161, GSE74195, and GSE86574 were used to identify DEGs, and a 17-gene metabolism-associated signature for prognosis prediction was established. The authors performed transcriptome and single-cell sequencing on medulloblastoma bulk specimens to further validate metabolic subclasses and the prognosis prediction model at the transcriptome and cellular level.
Conclusion: The present study classifies Medulloblastoma (MB) based on metabolic signatures, supplementing existing subtype characterization from a metabolic perspective. The authors provide preliminary insights into MB’s metabolic hallmarks and a potential reference for developing multimolecule-based personalized therapies and prognostic tools ‒ with the caveat that the 17-gene signature requires additional multi-center validation to confirm clinical utility.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
Datasets cited
- geo:GSE74195, at NCBI GEO; found in the text, “Identification of DGEs and survival-related…”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in “Data availability”
Data availability
The datasets used and/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Authors: added Zihan Yan (0009-0005-4543-7403); Yunwei Ou (0009-0006-3492-7754); Xu Han (0009-0009-8938-7478); Jian Gong (0009-0008-5996-4062); removed Zihan Yan; Yunwei Ou; Xu Han; Jian Gong
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 4 authors, 5 keywords, 1 funder, 37 references.
Cite
This paper
Yan, Z., Ou, Y., Han, X., & Gong, J. (2026). Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis. Clinics (Sao Paulo, Brazil), 81, 101003. https://
BibTeX
@article{yan2026identifi
author = {Yan, Zihan and Ou, Yunwei and Han, Xu and Gong, Jian},
title = {{Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis}},
journal = {Clinics (Sao Paulo, Brazil)},
year = {2026},
month = may,
volume = {81},
pages = {101003},
publisher = {Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo},
issn = {1807-5932},
doi = {10.1016/
url = {https://
pmid = {42150480},
pmcid = {PMC13202577}
}
RIS
TY - JOUR
AU - Yan, Zihan
AU - Ou, Yunwei
AU - Han, Xu
AU - Gong, Jian
TI - Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis
T2 - Clinics (Sao Paulo, Brazil)
J2 - Clinics (Sao Paulo)
PY - 2026
DA - 2026/
VL - 81
SP - 101003
SN - 1807-5932
PB - Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Identification of metabolism-associated molecular classification and prognostic genes for medulloblastoma based on bioinformatics analysis",
"container-title": "Clinics (Sao Paulo, Brazil)",
"author": [
{
"family": "Yan",
"given": "Zihan"
},
{
"family": "Ou",
"given": "Yunwei"
},
{
"family": "Han",
"given": "Xu"
},
{
"family": "Gong",
"given": "Jian"
}
],
"container-title-short":
"volume": "81",
"page": "101003",
"DOI": "10.1016/
"PMID": "42150480",
"PMCID": "PMC13202577",
"ISSN": "1807-5932",
"publisher": "Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
18
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41598-024-57549-2
- Identification and validation of a metabolism-related gene signature for predicting the prognosis of paediatric medulloblastoma.Journal: Scientific reportsIn common: NCBI GEO GSE74195, other condition, 4 references
- [2] doi:10.1093/noajnl/vdac144
- Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression.Journal: Neuro-oncology advancesIn common: NCBI GEO GSE74195, other condition, cellular / molecular, 2 references
- [3] doi:10.59249/qtvt7676
- ROCK2 Downregulation in Pediatric Medulloblastoma Increases Migration and Predicts the Involvement of SHH Non-canonical Signaling.Journal: The Yale journal of biology and medicineIn common: NCBI GEO GSE74195, other condition, cellular / molecular, 1 reference
- [4] doi:10.3389/fcell.2022.1007641
- Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma.Journal: Frontiers in cell and developmental biologyIn common: other condition, cellular / molecular, 3 references
- [5] doi:10.1038/s41598-026-37588-7
- Mitoxantrone alters CD24/
Siglec-10 expression in malignant brain tumor models. Journal: Scientific reportsIn common: other condition, 3 references - [6] doi:10.1111/jcmm.71154
- Mitophagy-Oxidative Stress Molecular Subtypes Define an Immunosuppressive Ecosystem and Vulnerabilities in Glioblastoma.Journal: Journal of cellular and molecular medicineIn common: genetics / omics, other condition, 3 references
- [7] doi:10.3390/ijms23179852
- Chromosomal Instability Characterizes Pediatric Medulloblastoma but Is Not Tolerated in the Developing Cerebellum.Journal: International journal of molecular sciencesIn common: other condition, cellular / molecular, 3 references
- [8] doi:10.1186/s40478-022-01326-7
- Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.Journal: Acta neuropathologica communicationsIn common: genetics / omics, other condition, 3 references
- [9] doi:10.1038/s41467-024-54352-5 [code]
- Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy.Journal: Nature communicationsIn common: genetics / omics, other condition, 3 references
- [10] doi:10.1126/sciadv.adn4649 [code]
- Childhood cancer mutagenesis caused by transposase-derived PGBD5.Journal: Science advancesIn common: other condition, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
